Send the following on WhatsApp
Continue to ChatThe aim was to conduct a systematic review and meta-analysis comparing mortality and severe adverse events among patients receiving ACEIs or ARBs. Results showed significant reductions in the risk of death and severe AEs. Findings support the recommendations of medical societies, they say, but future trials are needed to confirm causality. https://www.umdaa.co/blogs/260/association-between-renin-angiotensin-aldosterone-system-inhibitors-and-clinical-outcomes-in-patients-with-covid-19